Objectives: Ethnic differences in the prevalence of various chronic diseases, including end-stage renal disease, have been previously reported. Surprisingly, data focusing on the lower grade of chronic kidney disease (CKD) are scarce. Thus, the aim of this study was to explore differences in the prevalence of nephropathy between the Roma and non-Roma populations.
INTRODUCTION
Chronic kidney disease (CKD) is becoming a public threat due to high mortality, morbidity and costs associated with it (1-4). According to Levey et al., at least 12% of the US population suffer from CKD (5) . The exact prevalence of CKD in Slovakia has not yet been explored; in a report from the National Center for Health Information the total number of patients examined in any nephrology out-patient department during the year 2011 was more than 8% (6) .
Incidence of CKD in African Americans is 2-3 times higher compared with Caucasian Americans (7) . A similar variance in the incidence of CKD is found in India compared with Europe (8) and across European countries (4) . These differences were reported in well-being status, and their impact on various chronic diseases has been shown as well (4, (9) (10) (11) (12) (13) . Some of them could be attributed to genetic predisposition, others to modifiable health-risk factors or access to health care (11, 14) .
Regarding racial and ethnic differences, Roma are the major ethnic minority in Slovakia and as in the Czech Republic, Hungary and Romania this ethnicity represents an appreciable proportion of the overall population (15) . Several reports found associations between lower socioeconomic status, decreased health-related quality of life and higher prevalence of cardiovascular risk factors among Roma compared with non-Roma (9, 12, 13) . Thus far, studies focused on cardiovascular morbidity and mortality have shown a higher risk of death in Roma when controlled for socioeconomic status (16) . A recent report by Koľvek et al. suggests that Roma have 2.85-times higher risk of prevalence of end-stage renal disease (ESRD) compared with non-Roma (17) .
However, the comparison of CKD prevalence among Roma and the general population of Slovakia has not yet been studied. Therefore, the aim of this study was to explore the differences in the prevalence of nephropathy between Roma and non-Roma population.
Data from the cross-sectional HepaMeta study conducted in Slovakia in 2011 were used. The sample consisted of 452 Roma (mean age = 34.7; 35.2% men) and 403 non-Roma (mean age = 33.5; 45.9% men) respondents. Roma in selected settlements were recruited by local Roma community workers. Respondents from the major population were randomly selected from a list of patients from general practitioners. Data were collected via questionnaire, anthropometric measures and analysing blood samples. The methodology is described elsewhere (18) .
Statistical Analysis
Differences in nominal variables were explored using the χ 2 -test; while the t-test was used to explore differences in age and GFR between Roma and non-Roma. The odds ratio for the prevalence of nephropathy was calculated using binary logistic regression; the analysis was controlled by age and stratified by gender. The Statistical Package for the Social Science (IBM SPSS Inc. Chicago, IL, USA) version 20 was used for statistical analyses.
RESULTS
The mean age of the subjects was 34.1 ± 8.4 years, 344 were males (40.2%). Proteinuria was detected in 11 subjects (1.3%), hematuria in 113 subjects (13.2%), GFR < 60 ml/min in only 4 subjects (0.5%), and the mean GFR was 84 ± 12 ml/min. The prevalence of nephropathy as defined in the Methods section was thus 15.9% (136 subjects).
452 out of 855 subjects (52.9%) were Roma. There was a higher proportion of Roma females in the sample (293 Roma females vs. 218 non-Roma females; χ 2 = 10.2, p < 0.001) and Roma were significantly older (mean difference 1.2 years, t = −2.03, p < 0.05) ( Table 1) .
The prevalence of nephropathy in the total sample with regard to ethnicity is presented in Table 1 . The prevalence of nephropathy was higher in Roma than in non-Roma (OR 1.66; 95% CI 1.14-2.42; p < 0.01), similarly as the prevalence of proteinuria (OR 9.01; 95% CI 1.16-71.36; p < 0.05), and hematuria (OR 1.83; 95% CI 1.21-2.76; p < 0.01).
As there was a statistically significant difference in gender and age, we stratified the sample by gender and controlled analysis by age. In the age-adjusted model, Roma females had 56% higher odds for having nephropathy than non-Roma females (OR 1.56; 95% CI 1.01-2.42; p < 0.05). In addition, Roma females had significantly lower GFR (mean difference 3.4 ml/min, t = −3.58, p < 0.001); all 6 female patients with proteinuria were Roma (not significant). There were no differences in the prevalence of nephropathy in Roma males compared with non-Roma males (Table 2) .
DISCUSSION
In this study we explored ethnic differences in the prevalence of nephropathy between Roma and non-Roma populations. Roma ethnicity is associated with a 6.6% higher prevalence of nephropathy compared with non-Roma. The differences are striking among females (17.9% for non-Roma vs. 25.6% for Roma), with the odds for having nephropathy half-higher in Roma females than in non-Roma females. Similar to our findings, other studies explored also the fact that ethnic inequalities in Roma females compared with non-Roma females work together as a fundamental cause of poor well-being and are believed to increase their higher risk of illness (19, 20) .
Surprisingly, information about relevant prevalence of CKD in Roma across Europe is scarce. Recently, a Bulgarian study exploring the prevalence of CKD and its risk factors among 365 Roma and 1,261 non-Roma (21) was presented in poster form during a major European nephrology event. The authors showed the higher prevalence of albuminuria and/or decreased GFR in Roma (18.7%) compared with the non-Roma population. Roma ethnicity was associated with 7.3% higher frequency of CKD compared with the non-Roma population. The results are similar to our ones, despite their patients being older and with higher morbidity. However, the authors did not control their results for age or gender. On the other hand, they controlled the sample by socioeconomic status, arterial hypertension, overweight and obesity (21) . With regards to CKD, Molnár et al. have also shown that Roma kidney transplant recipients are at higher risk of mortality and worse graft outcomes independent of several sociodemographic and clinical determinants (14) .
Until now, data about ESRD have been available only in Slovakia; thus, "the tip of the iceberg" has already been explored: Koľvek et al. (17) found 1.34-times higher prevalence of ESRD in Roma. Approximately one-third of the entire Slovak dialysis population was explored, and the share of Roma among this dialysed population was 11.6%. At the time of dialysis initiation they were 10 years younger than non-Roma, and they more often Mean GFR (standard deviation) in ml/min 84 (13) 83 (12) GFR < 60 ml/s 3 1
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Strengths and Limitations
This study was strictly focused on the prevalence of CKD in Roma compared with non-Roma according to known risk factors (defined as history of any kidney disease, decreased GFR, and the presence of proteinuria or hematuria).
The design of this study has some limits to be mentioned. First, this is cross-sectional observational study and therefore we cannot predict how the observed pathologic indicators will evolve during the subsequent period. Because the observed population was relatively young (in their thirties), we can expect the prevalence of arterial hypertension and diabetes mellitus as well as the complications of these two diseases including CKD to rise. A second weakness of this study is the diagnostic utility. The HepaMeta study was not designed as nephrological; we assessed the presence of nephropathy mainly by using a dip-stick, which is cheap and simple method, but one with a low specificity, mainly when considering hematuria. Some cases of hematuria could be attributed to non-nephrologic bleeding (e.g. menstruation), others to non-progressive causes (e.g. uncomplicated cystitis), but many are false positive findings due to the use of certain drugs or consumption of certain foods (e.g. mangold). Transient hematuria is common (39% in the general population), but persistent hematuria (defined as urine positive in two out of three consecutive dipsticks, e.g. over a one to two weeks period) is estimated to occur in just 2.5-4.3% of adults seen in primary care. In clinical practice hematuria should be confirmed by urinary sediment evaluation and/or urinary tract imaging (22) .
Policy Implications
The presented results showing a higher prevalence of nephropathy in the young Roma population may provide us with "clues" for better observations, deeper preventive diagnostic procedures and relevant treatment interventions to prevent the progression of CKD. However, this study shows that the prevalence of nephropathy is mostly diagnosed due to hematuria, which could also be related to urinary or gynaecologic infections or other non-progressive "benign" lesions. For further research the measurement of albuminuria from the first morning void should be more specific.
Recommendations for Further Research
Our findings imply that Roma have a higher prevalence of nephropathy. The result must be verified in a longitudinal prospective study with a specific diagnostic utility, in line with up-to-date knowledge about the higher prevalence of CKD in Roma. Further studies should be carried out to shed more light on this important pathway. The risk of pathways encompassing ethnic differences (Roma vs. non-Roma) and the mentioned diagnostic determinants (as albuminuria, arterial hypertension, diabetes mellitus, nutrition status) should be studied as well.
CONCLUSION
The current cross-sectional study found in the young general population that Roma females have half-higher odds for nephropathy than non-Roma females. Therefore, we should focus on searching ethnic, social and medical determinants of CKD to prevent the risks. Interventions to decrease CKD incidence should also address ethnic inequalities as well as female gender.
